Horse Profile

Screener/Blue Nude (IRE)

Blue Nude (IRE)

4yo Gelding · Brown · IRE

Career Overview

Blue Nude (IRE) is a 4yo brown gelding, trained by P J Rothwell and owned by John Paul Flynn. He is by Sumbal (IRE), out of Line Perle (FR), by Gold And Steel, bred by Cyril O'Hara. From 5 career starts, he is yet to win, at a 0.0% strike rate.

AI summary — career highlights, form & what to expect

Blue Nude (IRE)(IRE)

Sumbal (IRE) — Line Perle (FR) (Gold And Steel)

Form
08080
Active

Age

4

Sex

Gelding

Colour

Brown

OR

—

TF

—

Runs

5

Wins

0

Places

0

BreederCyril O'Hara
Prize Money£0

Performance Metrics

Win Rate

0.0%

Place Rate

0.0%

Total Runs

5

Best OR

—

Career Earnings

£0

Ratings & Form History

Official Rating · Speed Figure · Finishing Position

28 Apr 2606 Jul 2623 Jul 2628 Aug 2607 Sep 26
  • Finish Pos.
  • Off. Rating
  • Speed Fig.

Pedigree

Breeder

Cyril O'Hara

Racing TypeJumps
ColourBrown
StatusActive

Performance Analysis

Going Preference

Good3
0W 0P 0%
Yielding2
0W 0P 0%

Seasonal Form

Sept1
0W 0P 0%
Apr1
0W 0P 0%
Jul2
0W 0P 0%
Aug1
0W 0P 0%

Headgear Impact

Without5
0W 0P 0%

Jockey Record

Course Form

Wexford (IRE)2
0W 0P 0%
Galway (IRE)1
0W 0P 0%
Roscommon1
0W 0P 0%
Punchestown1
0W 0P 0%

Beaten Distances

Avg Win Margin

—

Avg Beaten

11.0L

Closest Loss

0.3L

Market Trend (Starting Price)

28 Apr 2606 Jul 2623 Jul 2628 Aug 2607 Sep 2602505007501000
  • SP (dec)
  • BSP

Race History

Race History

DatePosTrackRaceDistGoingJockeySPORSpeed
07 Sep 202618Galway (IRE)Kenny Developments Maiden Hurdle16.5ffYieldingTiernan Power Roche250/1——
28 Aug 20268Wexford (IRE)Adare Manor Opportunity Maiden Hurdle17ffGoodConor Clarke125/1——
23 Jul 202611Wexford (IRE)Kilmore Quay (C & G) Maiden Hurdle16.5ffGoodTiernan Power Roche300/1——
06 Jul 20268RoscommonAdare Manor Opportunity Maiden Hurdle20.5ffGoodShane O'Callaghan250/1——
28 Apr 202616PunchestownWillie Coonan Memorial Flat Race16.5ffYieldingMiss P Elvin125/1——

Discussion

0 comments

You must be logged in to leave a comment.

No comments yet

Be the first to share your thoughts